-+ 0.00%
-+ 0.00%
-+ 0.00%

HUMACYTE AT ASN KIDNEY WEEK: PHASE 3 TRIAL BUILT FOR WOMEN SHOWS ATEV ADVANTAGE OVER FISTULA, GETTING PATIENTS OFF CATHETERS MONTHS SOONER

Reuters·10/23/2026 12:00:00

Please log in to view news